A detailed history of Cva Family Office, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Cva Family Office, LLC holds 194 shares of AUPH stock, worth $1,420. This represents 0.0% of its overall portfolio holdings.

Number of Shares
194
Previous 194 -0.0%
Holding current value
$1,420
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

BUY
$4.81 - $5.78 $933 - $1,121
194 New
194 $1,000
Q4 2023

Jan 16, 2024

BUY
$7.13 - $9.49 $991 - $1,319
139 New
139 $1,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.04B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Cva Family Office, LLC Portfolio

Follow Cva Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cva Family Office, LLC with notifications on news.